COMMUNIQUÉS West-GlobeNewswire

Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
12/03/2024
Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients GROTON, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company committed to [...]
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
12/03/2024
EAGLE, Idaho, March 12, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
12/03/2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group ") (CSE: PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and [...]
Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
12/03/2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food [...]
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
12/03/2024
GRANTS, NEW MEXICO, March 12, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed an agreement with Dalsem Greenhouse Technologies BV for [...]
Middlesex Recovery Earns Three-Year CARF Accreditation
12/03/2024
LEWISVILLE, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Middlesex Recovery is proud to announce that it has earned a Three-Year Accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF) for [...]
EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research
12/03/2024
Vision 2030 will utilize advanced technologies and an innovative operating model for research and drug development SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- EverythingALS, a leading force in the fight against [...]
Health-ISAC Supports Health Industry Cybersecurity Strategic Plan
12/03/2024
Joint effort gives measurable objectives toward resilience within 5 years ORMOND BEACH, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- Health-ISAC, a non-profit, member driven organization is pleased to contribute to the [...]
Love for Liam Foundation to Host the Third Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 10, 2024
12/03/2024
PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- The Love for Liam Foundation , a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced its Third Annual [...]
Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO
12/03/2024
PLEASANTON, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a frontrunner in healthcare technology has announced the appointment of [...]
Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million
12/03/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a [...]
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY
12/03/2024
Rutherford, NJ, March 12, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel [...]
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
12/03/2024
Keynote Will Discuss Cellular Immunotherapy’s Potential for Treating Chronic Conditions, Including Cancer, Multiple Sclerosis and Parkinson’s Disease FLORHAM PARK, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Celularity Inc [...]
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
12/03/2024
ART26.12 Preclinical Dermatology Research Presented to the Immuno-dermatology Leadership Team at Johnson & Johnson SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a [...]
Sharecare provides strategic update
12/03/2024
Independent special committee of the Sharecare Board of Directors reviewing multiple proposals ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ) has been evaluating a range of options including a [...]
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
12/03/2024
Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screening Southlake, Texas, March 12, 2024 (GLOBE NEWSWIRE [...]
HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
12/03/2024
HeartFlow's non-invasive AI driven FFR CT predicts patient outcomes as effectively as the gold-standard invasive FFR out to 10 years MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in [...]
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
12/03/2024
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Nasdaq [...]
Sharecare reschedules issuance of fourth quarter and full year 2023 earnings release and investor conference call
12/03/2024
ATLANTA, March 12, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR ), the digital health company that helps people manage all their health in one place, today announced that it has postponed the release of its [...]

Pages